NPIPA9
gene geneOn this page
Summary
NPIPA9 (nuclear pore complex interacting protein family member A9, HGNC:41984) is a protein-coding gene on chromosome 16p12.3, encoding Nuclear pore complex-interacting protein family member A9 (A0A0B4J1W7).
At a glance
- MANE Select transcript:
NM_001405004
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41984 |
| Approved symbol | NPIPA9 |
| Name | nuclear pore complex interacting protein family member A9 |
| Location | 16p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000233024 |
| Ensembl biotype | protein_coding |
| Entrez | 105376752 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 5 protein_coding, 2 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000327792, ENST00000427999, ENST00000526166, ENST00000528301, ENST00000531453, ENST00000533010, ENST00000543228, ENST00000545114, ENST00000546267
RefSeq mRNA: 2 — MANE Select: NM_001405004
NM_001401710, NM_001405004
CCDS: CCDS92118
Canonical transcript exons
ENST00000427999 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001644947 | 18376736 | 18376839 |
| ENSE00001681998 | 18361170 | 18361277 |
| ENSE00001688624 | 18360093 | 18360153 |
| ENSE00001715994 | 18359948 | 18359983 |
| ENSE00001764925 | 18372723 | 18372854 |
| ENSE00002163343 | 18358090 | 18358588 |
| ENSE00003501612 | 18368258 | 18368386 |
| ENSE00003578732 | 18374832 | 18375069 |
| ENSE00003669626 | 18364535 | 18364634 |
| ENSE00003684737 | 18364227 | 18364371 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.63.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar hemisphere | UBERON:0002245 | 99.63 | gold quality |
| cerebellar cortex | UBERON:0002129 | 99.60 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 99.58 | gold quality |
| cerebellum | UBERON:0002037 | 99.52 | gold quality |
| right uterine tube | UBERON:0001302 | 99.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 99.39 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 99.24 | gold quality |
| pituitary gland | UBERON:0000007 | 99.21 | gold quality |
| right ovary | UBERON:0002118 | 98.60 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.53 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.49 | gold quality |
| sural nerve | UBERON:0015488 | 98.47 | gold quality |
| corpus callosum | UBERON:0002336 | 98.46 | gold quality |
| left ovary | UBERON:0002119 | 98.40 | gold quality |
| body of uterus | UBERON:0009853 | 98.29 | gold quality |
| ovary | UBERON:0000992 | 98.19 | gold quality |
| body of pancreas | UBERON:0001150 | 98.04 | gold quality |
| tibial nerve | UBERON:0001323 | 97.92 | gold quality |
| fallopian tube | UBERON:0003889 | 97.76 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 97.76 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 97.71 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.68 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 97.61 | gold quality |
| lower esophagus | UBERON:0013473 | 97.57 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.57 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.48 | gold quality |
| Ammon’s horn | UBERON:0001954 | 97.38 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 97.37 | gold quality |
| left uterine tube | UBERON:0001303 | 97.35 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.79 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB13 (ENSG00000198064), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member A9 — A0A0B4J1W7 (reviewed: A0A0B4J1W7)
All UniProt accessions (3): A0A0B4J1W7, H0YF59, Q9NRE7
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the NPIP family.
RefSeq proteins (2): NP_001388639, NP_001391933* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A0B4J1W7-F1 | 50.59 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
chr16p12, PAF1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
447 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPIPA9 | UEVLD | Q8IX04 | 135 |
| NPIPA9 | CHDH | Q8NE62 | 102 |
| NPIPA9 | AMOT | Q4VCS5 | 102 |
| NPIPA9 | AMOTL1 | Q8IY63 | 102 |
| NPIPA9 | HSPA9 | P30036 | 92 |
| NPIPA9 | CARD9 | Q9H257 | 92 |
| NPIPA9 | SPNS2 | Q8IVW8 | 91 |
| NPIPA9 | CAT | P04040 | 83 |
| NPIPA9 | SRP54 | P13624 | 81 |
| NPIPA9 | HAS1 | Q92839 | 80 |
| NPIPA9 | HAS3 | O00219 | 80 |
| NPIPA9 | HAS2 | Q92819 | 80 |
| NPIPA9 | RHBDL3 | P58872 | 71 |
| NPIPA9 | DHX9 | Q08211 | 71 |
| NPIPA9 | ACP5 | P13686 | 70 |
| NPIPA9 | SHMT1 | P34896 | 70 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0B4J1W7, A0A7H0DN35, A4QN01, A6NHN6, A6NJ64, A8MQ11, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F5HGC2, F8W1W9, F8WFD2, O75200, O83374, P05913, P06486, P07396, P0C7Q2, P0CK47, P0CK48, P0DM63, P0DXC3, P15489, P16765, P16802, P20969, P36443, P38900, P47003, P68341, P68454, P68455, P87191, P92537, P92561, Q03418, Q32M92, Q4ZGE2
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2400 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:18360144:A:C | F185L | 0.969 |
| 16:18360144:A:T | F185L | 0.969 |
| 16:18360146:A:G | F185L | 0.969 |
| 16:18368342:A:C | F36L | 0.935 |
| 16:18368342:A:T | F36L | 0.935 |
| 16:18368344:A:G | F36L | 0.935 |
| 16:18368306:A:C | F48L | 0.927 |
| 16:18368306:A:T | F48L | 0.927 |
| 16:18368308:A:G | F48L | 0.927 |
| 16:18361182:A:G | I178T | 0.917 |
| 16:18364343:A:C | F107L | 0.917 |
| 16:18364343:A:T | F107L | 0.917 |
| 16:18364345:A:G | F107L | 0.917 |
| 16:18368329:A:G | W41R | 0.903 |
| 16:18368329:A:T | W41R | 0.903 |
| 16:18358580:C:A | M217I | 0.888 |
| 16:18358580:C:G | M217I | 0.888 |
| 16:18358580:C:T | M217I | 0.888 |
| 16:18364626:G:C | F67L | 0.881 |
| 16:18364626:G:T | F67L | 0.881 |
| 16:18364628:A:G | F67L | 0.881 |
| 16:18361182:A:T | I178K | 0.861 |
| 16:18359982:A:G | I203T | 0.855 |
| 16:18360093:T:A | K202N | 0.852 |
| 16:18360093:T:G | K202N | 0.852 |
| 16:18360145:A:G | F185S | 0.844 |
| 16:18361216:C:G | A167P | 0.842 |
| 16:18361182:A:C | I178R | 0.835 |
| 16:18364620:C:A | K69N | 0.832 |
| 16:18364620:C:G | K69N | 0.832 |
dbSNP variants (sampled 300 via entrez): RS1001067255 (16:18375045 G>A), RS1006153988 (16:18374477 G>A,C,T), RS1012267341 (16:18364657 T>C), RS1012697636 (16:18375022 G>A), RS1014130990 (16:18374738 A>G), RS1015954368 (16:18371548 A>G), RS1015988762 (16:18367575 A>G), RS1020788330 (16:18374497 G>A), RS1023819792 (16:18374765 C>G,T), RS1025792506 (16:18371566 T>A), RS1028642669 (16:18367296 C>T), RS1029361009 (16:18371430 C>A,G,T), RS1030811629 (16:18365183 A>T), RS1032523952 (16:18375134 C>G,T), RS1035881972 (16:18374660 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | increases expression | 1 |
| Vehicle Emissions | increases abundance, decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.